GlassScriptPhysician profile
Jeffrey A Frederick
NPI 1093743957
$1,528.56
in general payments reported to CMS, 2019-2025
11 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $125 · 2023: $475 · 2024: $356 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,271.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $553.94 | 2021-2025 | Dupixent |
| Genzyme Corporation | $535.84 | 2022-2025 | |
| Glaxosmithkline, LLC. | $178.19 | 2023-2025 | Nucala |
| Optinose US, INC. | $90.68 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $43.14 | 2021 | |
| Hikma Pharmaceuticals USA | $29.29 | 2023-2024 | Ryaltris |
| Aerin Medical INC. | $25.88 | 2023 | |
| Cochlear Americas | $24.10 | 2023 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Astrazeneca Pharmaceuticals LP | $22.65 | 2025 | Tezspire |
| Greer Laboratories, INC. | $13.56 | 2022 | |
| Merck Sharp & Dohme LLC | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.